Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
5,467,783
-
Share change
-
+153,258
-
Total reported value
-
$359,359,917
-
Price per share
-
$65.72
-
Number of holders
-
156
-
Value change
-
+$8,463,665
-
Number of buys
-
64
-
Number of sells
-
48
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2024
As of 31 Dec 2024,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,467,783 shares.
The largest 10 holders included
Fisher Asset Management, LLC, MORGAN STANLEY, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, Royal Bank of Canada, GOLDMAN SACHS GROUP INC, BROWN ADVISORY INC, LPL Financial LLC, RAYMOND JAMES FINANCIAL INC, and TWO SIGMA INVESTMENTS, LP.
This page lists
156
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.